Number of patients who were provided with the service with the main diagnosis C34 (lung cancer) or the main diagnosis Z51 and the comorbid diagnosis C34, and the value of benefits: Difference between revisions

From Beacon
No edit summary
No edit summary
Line 2: Line 2:
{{forresearchers}}
{{forresearchers}}


'''Type of Information''': [[availableVariable::year]]; [[availableVariable::sex]]; [[availableVariable::age]] group; Type of benefit; [[availableVariable::costs reimbursement|Refund value]] and [[availableVariable::number of patients]].
'''Type of Information''': [[availableVariable::year]]; [[availableVariable::sex]]; [[availableVariable::age]] group; [[availableVariable::health service utilization|Type of benefit]]; [[availableVariable::costs reimbursement|Refund value]] and [[availableVariable::number of patients]].


'''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-09.
'''Source of Information''': Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-09.

Revision as of 13:40, 8 December 2023

Go back to Poland page

Type of Information: year; sex; age group; Type of benefit; Refund value and number of patients.

Source of Information: Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-09.

Data level: national level.

Number of Records: unknown.

Date Range: 2013-2020.

Cancer Areas of Interest: bronchial and lung cancer (C34); encounter for other aftercare and medical care (Z51).

Open data access: publicly available [1].

Information/Contact for data request: Contact information [2].